Researchers found that 160 milligrams of daily aspirin significantly lowered cancer recurrence risk for colorectal patients with PIK3 pathway alterations.

A study involving more than 1,000 cancer patients has found that a low dose of aspirin halves the risk of colorectal tumors ...

A low dose reduces the likelihood of recurrence in people who have had surgery to remove tumors with a common genetic mutation, study finds.

A low dose of the well-known medicine aspirin halves the risk of recurrence after surgery in patients with colon and rectal ...

A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical trial that a low dose of the well-known medicine aspirin halves the risk ...

A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized ...

A groundbreaking new clinical trial has found that taking a low dose of the common fever medicine Aspirin halves the risk of ...

A daily low dose of aspirin could sharply cut the risk of colorectal cancer returning after surgery, according to a large ...

There is not a financial incentive to produce them, which is an issue in high-income countries like the US and the UK.” ...

A groundbreaking Swedish study has demonstrated that taking aspirin daily can slash the likelihood of colorectal cancer returning by more than half in certain patients. The research revealed that ...

Aspirin can cut by more than half the risk that colon cancer will come back following initial treatment, a new Karolinska ...